{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:18:36Z","timestamp":1785568716970,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajoc.2026.102549","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:43:27Z","timestamp":1771605807000},"page":"102549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Topical losartan to prevent stromal scarring during post-cross-linking infection in pediatric keratoconus: A case report"],"prefix":"10.1016","volume":"42","author":[{"given":"Francesca","family":"Barzaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kronschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahand","family":"Amir-Asgari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1393-1598","authenticated-orcid":false,"given":"Oliver","family":"Findl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2026.102549_bib1","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00417-024-06710-8","article-title":"Topical losartan ophthalmic drops: a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications","volume":"263","author":"Abdelghaffar","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102549_bib2","article-title":"Topical losartan for treating corneal haze after Pseudomonas keratitis: a case report","volume":"10","author":"D'Ancona","year":"2025","journal-title":"Ann Eye Sci"},{"key":"10.1016\/j.ajoc.2026.102549_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/aos.14704","article-title":"Mitomycin C for the prevention of corneal haze in photorefractive keratectomy: a meta-analysis and trial sequential analysis","volume":"99","author":"Chang","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102549_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3928\/1081597X-20221018-02","article-title":"Topical losartan for treating corneal fibrosis (haze): first clinical experience","volume":"38","author":"Pereira-Souza","year":"2022","journal-title":"J Refract Surg"},{"key":"10.1016\/j.ajoc.2026.102549_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/pgmj.52.612.634","article-title":"Steroids and the eye\u2014indications and complications","volume":"52","author":"Dinning","year":"1976","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajoc.2026.102549_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajoc.2026.102549_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108325","article-title":"TGF\u03b21 and TGF\u03b22 proteins in corneas with and without stromal fibrosis","volume":"202","author":"de Oliveira","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2026.102549_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/jop.2022.0174","article-title":"Topical losartan: practical guidance for clinical trials in the prevention and treatment of corneal scarring fibrosis and other eye diseases and disorders","volume":"39","author":"Wilson","year":"2023","journal-title":"J Ocul Pharmacol Therapeut"},{"key":"10.1016\/j.ajoc.2026.102549_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.109884","article-title":"Two-phase mechanism in the treatment of corneal stromal fibrosis with topical losartan","volume":"242","author":"Wilson","year":"2024","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2026.102549_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1167\/iovs.61.2.28","article-title":"Fibrocytes, wound healing, and corneal fibrosis","volume":"61","author":"de Oliveira","year":"2020","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2026.102549_bib11","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","article-title":"Clinical pharmacokinetics of losartan","volume":"44","author":"Sica","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajoc.2026.102549_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.66574\/001c.126743","article-title":"Point-counter point: treating corneal haze with 0.8 mg\/mL topical losartan","volume":"2","author":"Pucker","year":"2024","journal-title":"Clin Insights Eyecare"},{"key":"10.1016\/j.ajoc.2026.102549_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108940","article-title":"Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits","volume":"216","author":"Sampaio","year":"2022","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajoc.2026.102549_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.11.7.9","article-title":"Topical losartan and corticosteroid additively inhibit corneal stromal myofibroblast generation and scarring fibrosis after alkali burn injury","volume":"11","author":"Sampaio","year":"2022","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ajoc.2026.102549_bib15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000545215","article-title":"Topical losartan treatment of HSV- or VZV-induced corneal scarring: a case series","volume":"16","author":"Dutra","year":"2025","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102549_bib16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.12669\/pjms.41.3.11237","article-title":"Effect of 0.8 mg\/mL losartan on corneal opacities","volume":"41","author":"Fawad","year":"2025","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.ajoc.2026.102549_bib17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1055\/s-0042-100626","article-title":"Keratoconus: the ABCD grading system","volume":"233","author":"Belin","year":"2016","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.ajoc.2026.102549_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajo.2020.12.011","article-title":"Individualized corneal cross-linking with riboflavin and UV-A in ultrathin corneas: the Sub400 protocol","volume":"224","author":"Hafezi","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102549_bib19","series-title":"Preferred Practice Pattern\u00ae Guidelines: Bacterial Keratitis","year":"2023"},{"key":"10.1016\/j.ajoc.2026.102549_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4103\/ijo.IJO_4_23_4","article-title":"Commentary: tackling childhood infectious keratitis","volume":"71","author":"Onkar","year":"2023","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ajoc.2026.102549_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/ICO.0000000000002957","article-title":"Pediatric microbial keratitis: identification of clinical biomarkers for prognosis and outcome of 218 cases from 2009 to 2019","volume":"41","author":"Di Zazzo","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102549_bib22","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.ophtha.2021.04.019","article-title":"Effect of corneal cross-linking versus standard care on keratoconus progression in young patients: the KERALINK randomized controlled trial","volume":"128","author":"Larkin","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2026.102549_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/j.jcrs.0000000000000620","article-title":"Infectious keratitis after corneal crosslinking: systematic review","volume":"47","author":"Murchison","year":"2021","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.ajoc.2026.102549_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.9734\/jammr\/2024\/v36i95581","article-title":"Systematic review of losartan eye drops in managing post-surgical corneal haze","volume":"36","author":"da Silva Oliveira","year":"2024","journal-title":"J Adv Med Med Res"},{"key":"10.1016\/j.ajoc.2026.102549_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/iovs.63.1.22","article-title":"Corneal opacity: cell biological determinants of the transition from transparency to transient haze to scarring fibrosis, and resolution, after injury","volume":"63","author":"Wilson","year":"2022","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2026.102549_bib26","article-title":"Topical losartan for corneal fibrosis: a case series with densitometry analysis","author":"Burgos-Blasco","year":"2024","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102549_bib27","article-title":"The potential role of topical losartan in reducing subepithelial haze in traumatic LASIK flap avulsion","volume":"17","author":"LoBue","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.ajoc.2026.102549_bib28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/ICO.0000000000003725","article-title":"Topical losartan dosage response and corneal toxicity at higher concentrations","volume":"44","author":"Dutra","year":"2024","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102549_bib29","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/01.ico.0000225720.38748.58","article-title":"Corneal cross-linking-induced stromal demarcation line","volume":"25","author":"Seiler","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.ajoc.2026.102549_bib30","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2147\/OPTH.S117372","article-title":"Corneal stromal demarcation line after collagen cross-linking in corneal ectatic diseases: a review of the literature","volume":"10","author":"Spadea","year":"2016","journal-title":"Clin Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362600037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362600037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:48:50Z","timestamp":1784216930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199362600037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S245199362600037X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102549","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical losartan to prevent stromal scarring during post-cross-linking infection in pediatric keratoconus: A case report","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2026.102549","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102549"}}